Showing 2631 results
- https://www.novartis.com/news/media-releases/novartis-peer-reviewed-safety-and-tolerability-data-further-strengthens-kesimptas-ofatumumab-favorable-benefit-risk-profile-patients-relapsing-multiple-sclerosisMultiple Sclerosis Journal has published data from the ALITHIOS open-label extension study which provide a robust picture of the continuous safety data for Kesimpta, showing it was well tolerated in…
- https://www.novartis.com/news/media-releases/sandoz-launches-generic-lenalidomide-19-countries-across-europe-expanding-access-essential-oncology-medicineLenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines1,4Cost savings from Lenalidomide Sandoz can expand treatment options for…
- https://www.novartis.com/news/media-releases/novartis-delivers-mid-single-digit-sales-growth-margin-expansion-and-advancement-robust-pipeline-2021Ad hoc announcement pursuant to Art. 53 LR Q4 sales grew +6% (cc1, +4% USD) and core operating income grew +12% (cc, +9% USD) IM sales grew +7% (cc, +5% USD) and core operating income +15% (cc, +12…
- https://www.novartis.com/news/media-releases/novartis-solide-croissance-du-chiffre-daffaires-et-du-benefice-la-forte-performance-des-marques-existantes-soutient-la-confiance-dans-les-previsions-de-croissance-moyen-termeAnnonce événementielle selon l’art. 53 RC Chiffre d’affaires du T1 en hausse de +5% (tcc1, +1% USD) et résultat opérationnel core en progression de 9% (tcc, +3% USD) Innovative Medicines (IM):…
- https://www.novartis.com/news/media-releases/novartis-erzielt-ein-solides-umsatz-und-gewinnwachstum-die-starke-performance-auf-dem-markt-befindlicher-marken-stutzt-das-vertrauen-die-mittelfristigen-wachstumsaussichtenAd-hoc-Mitteilung gemäss Art. 53 KR Der Umsatz stieg im ersten Quartal um +5% (kWk1, +1% USD), das operative Kernergebnis wuchs um +9% (kWk, +3% USD) Innovative Medicines (IM) steigerte…
- https://www.novartis.com/news/world-chagas-disease-day-2021
Together with partners, Novartis is committed to reimagining the fight against Chagas disease and advocating for an integrated, end-to-end care approach.
- https://www.novartis.com/careers/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/joanne-wong-phd
- https://www.novartis.com/news/amazon-web-services-aws-announces-strategic-collaboration-novartis-accelerate-digital-transformation-its-business-operations
We’re collaborating with AWS to build an enterprise-wide data and analytics platform to transform the way medicines are manufactured and delivered.
- https://www.novartis.com/news/novartis-opens-facility-innovative-cell-and-gene-therapies-switzerland
New cell and gene manufacture in Stein offers hope for patients around the globe.
- https://www.novartis.com/news/world-sight-day-2019
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 264
- › Next page